Table 5. Time delays, in percentiles, in the receipt of doses of hepatitis B vaccine for children aged 12–60 months in 47 countries, by national hepatitis B vaccination schedule.
Vaccination schedulea and vaccine type | Country or median for vaccination schedule | First dose |
Third dose |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of children vaccinated | Delay percentiles, weeks |
No. of children vaccinated | Delay percentiles, weeks |
|||||||||
25th | 50th | 75th | IQR | 25th | 50th | 75th | IQR | |||||
Weeks 0, 4, 13 | ||||||||||||
Monovalent | Maldives | 2042 | 0.1 | 0.3 | 1.0 | 0.9 | 2036 | 5.9 | 7.9 | 11.9 | 6.0 | |
Weeks 0, 4, 26 | ||||||||||||
Monovalent | Republic of Moldova | 1040 | 0.0 | 0.0 | 0.1 | 0.1 | 1062 | 0.6 | 2.3 | 5.6 | 5.0 | |
Weeks 0, 6, 14 | ||||||||||||
Monovalent | Nigeria | 3661 | 1.7 | 4.7 | 9.4 | 7.7 | 3043 | 1.0 | 5.4 | 14.7 | 13.7 | |
Weeks 0, 6, 26 | ||||||||||||
Monovalent | Armenia | 1 016 | 0.1 | 0.3 | 0.6 | 0.4 | 943 | 2.0 | 6.1 | 13.0 | 11.0 | |
Weeks 0, 9, 17 | ||||||||||||
Monovalent |
Azerbaijan | 760 |
0.0 |
0.0 |
4.4 |
4.4 |
622 |
0.9 |
3.1 |
10.1 |
9.3 |
|
Monovalent |
Tajikistan |
2981 |
0.0 |
0.0 |
0.3 |
0.3 |
2750 |
−3.3 |
−1.1 |
3.0 |
6.3 |
|
N/A |
Median | 1541 | 0.0 | 0.0 | 2.4 | 2.4 | 1499 |
−1.2 |
1.0 |
6.6 |
7.8 |
|
Weeks 0, 9, 22 |
||||||||||||
Monovalent |
Kyrgyzstan | 2244 | 0.0 | 0.1 | 0.1 | 0.1 | 2054 |
−6.1 |
−3.3 |
2.1 |
8.3 |
|
Weeks 0, 9, 26 |
||||||||||||
Monovalent |
Albania | 798 | 0.1 | 0.1 | 0.3 | 0.2 | 758 |
0.4 |
1.1 |
2.7 |
2.3 |
|
Weeks 4, 8, 12 |
||||||||||||
Tetravalent |
United Republic of Tanzania | 3367 | 0.9 | 2.3 | 5.1 | 4.3 | 3223 |
2.4 |
5.6 |
11.9 |
9.4 |
|
Pentavalent |
Uganda | 801 | 2.7 | 4.1 | 7.9 | 5.2 | 700 |
4.6 |
8.6 |
17.7 |
13.1 |
|
N/A | Median | 2084 | 1.8 | 3.2 | 6.5 | 4.7 | 1962 | 3.5 | 7.1 | 14.8 | 11.3 | |
Weeks 6, 10, 14 | ||||||||||||
Monovalent | Bangladesh | 3583 | 1.0 | 2.6 | 4.3 | 3.3 | 3428 | 2.6 | 4.7 | 8.7 | 6.1 | |
Monovalent | Cameroon | 1745 | 0.3 | 1.1 | 3.9 | 3.6 | 1607 | 1.1 | 3.1 | 7.7 | 6.6 | |
Monovalent | Gabon | 793 | 0.4 | 1.1 | 5.1 | 4.7 | 627 | 1.9 | 4.7 | 13.0 | 11.1 | |
Monovalent | Lesotho | 739 | 0.4 | 1.1 | 2.9 | 2.4 | 643 | 2.0 | 3.7 | 7.9 | 5.9 | |
Monovalent | Pakistan | 560 | 1.0 | 2.7 | 6.1 | 5.1 | 508 | 3.1 | 5.9 | 13.4 | 10.3 | |
Monovalent | Swaziland | 1347 | 0.1 | 0.4 | 1.3 | 1.2 | 1315 | 0.7 | 1.7 | 4.6 | 3.9 | |
Monovalent | Timor-Leste | 1971 | 0.4 | 3.0 | 7.6 | 7.1 | 1853 | 2.6 | 6.1 | 12.9 | 10.3 | |
Bivalent | Benin | 2076 | 0.1 | 1.0 | 3.4 | 3.3 | 1877 | 1.3 | 4.0 | 9.4 | 8.1 | |
Tetravalent | Madagascar | 1993 | 0.4 | 2.0 | 4.7 | 4.3 | 1891 | 1.9 | 4.0 | 9.3 | 7.4 | |
Tetravalent | Mozambique | 5282 | 2.7 | 4.0 | 7.7 | 5.0 | 4764 | 4.6 | 9.3 | 19.3 | 14.7 | |
Pentavalent | Burundi | 1335 | 0.6 | 1.1 | 2.6 | 2.0 | 1298 | 2.0 | 3.4 | 6.6 | 4.6 | |
Pentavalent | Cambodiab | 2443 | 0.6 | 0.9 | 2.7 | 2.1 | 2286 | 1.6 | 3.0 | 6.9 | 5.3 | |
Pentavalent | Comoros | 1088 | 0.4 | 1.1 | 4.0 | 3.6 | 1032 | 2.0 | 5.0 | 13.6 | 11.6 | |
Pentavalent | Côte d’Ivoire | 1363 | 0.6 | 2.0 | 5.6 | 5.0 | 1120 | 2.9 | 5.9 | 14.3 | 11.4 | |
Pentavalent | Democratic Republic of the Congo | 914 | 0.3 | 1.7 | 5.0 | 4.7 | 780 | 1.3 | 3.7 | 9.7 | 8.4 | |
Pentavalent | Ghana | 1587 | 0.3 | 1.1 | 3.1 | 2.9 | 1539 | 1.4 | 3.3 | 6.6 | 5.1 | |
Pentavalent | Kenya | 2413 | 0.1 | 1.0 | 3.4 | 3.3 | 2302 | 0.9 | 2.6 | 6.6 | 5.7 | |
Pentavalent | Liberia | 862 | 0.4 | 1.7 | 5.0 | 4.6 | 749 | 2.1 | 6.4 | 17.0 | 14.9 | |
Pentavalent | Malawi | 2341 | 0.7 | 2.4 | 5.0 | 4.3 | 2309 | 2.6 | 5.6 | 11.0 | 8.4 | |
Pentavalent | Mali | 309 | 0.7 | 2.9 | 8.3 | 7.6 | 275 | 3.9 | 7.3 | 19.4 | 15.6 | |
Pentavalent | Namibia | 814 | 0.0 | 0.4 | 1.0 | 1.0 | 796 | 0.6 | 1.4 | 3.9 | 3.3 | |
Pentavalent | Niger | 1148 | 0.6 | 2.6 | 7.0 | 6.4 | 1062 | 3.1 | 7.3 | 16.6 | 13.4 | |
Pentavalent | Rwanda | 2386 | 0.4 | 1.0 | 2.3 | 1.9 | 2351 | 1.1 | 2.4 | 4.4 | 3.3 | |
Pentavalent | Senegal | 2277 | 0.6 | 1.7 | 4.7 | 4.1 | 2084 | 2.1 | 5.3 | 11.1 | 9.0 | |
Pentavalent | Sierra Leoneb | 2072 | 0.0 | 1.3 | 4.9 | 4.9 | 1891 | 2.4 | 7.3 | 17.0 | 14.6 | |
Pentavalent | Zambia | 6136 | 0.4 | 2.0 | 5.4 | 5.0 | 5697 | 2.4 | 6.3 | 15.0 | 12.6 | |
N/A | Median | 1587 | 0.4 | 1.5 | 4.7 | 4.2 | 1573 | 2.0 | 4.7 | 10.4 | 8.4 | |
Weeks 9, 13, 17 | ||||||||||||
Monovalent | Jordan | 3598 | 0.0 | 0.7 | 2.1 | 2.1 | 3523 | 1.6 | 3.1 | 6.1 | 4.6 | |
Pentavalent | Congo | 1155 | −0.1 | 0.4 | 2.7 | 2.9 | 1014 | 0.7 | 2.1 | 5.6 | 4.9 | |
Pentavalent | Burkina Faso | 3447 | −0.4 | 0.4 | 2.4 | 2.9 | 3350 | 0.7 | 2.7 | 6.4 | 5.7 | |
N/A | Median | 3447 | −0.1 | 0.4 | 2.4 | 2.9 | 3350 | 0.7 | 2.7 | 6.1 | 4.9 | |
Weeks 9, 17, 26 | ||||||||||||
Monovalent | Egypt | 4612 | −0.3 | 0.1 | 0.9 | 1.2 | 4093 | 0.3 | 0.9 | 2.3 | 2.0 | |
Monovalent | Colombiab | 8431 | −0.1 | 0.3 | 2.1 | 2.3 | 8161 | 0.4 | 1.7 | 6.1 | 5.7 | |
Pentavalent | Bolivia (Plurinational State of) | 4631 | −0.1 | 1.0 | 4.3 | 4.4 | 4292 | 0.4 | 3.0 | 10.0 | 9.6 | |
Pentavalent | Dominican Republicb | 1434 | −0.1 | 0.1 | 1.4 | 1.6 | 1224 | 1.0 | 2.1 | 6.0 | 5.0 | |
Pentavalent | Guyana | 1044 | −0.1 | 1.0 | 3.6 | 3.7 | 1018 | 1.1 | 3.3 | 8.1 | 7.0 | |
Pentavalent | Honduras | 6516 | −0.3 | 0.0 | 1.0 | 1.3 | 6445 | 0.6 | 1.7 | 4.7 | 4.1 | |
Pentavalent | Perub | 4225 | −0.3 | 0.0 | 1.4 | 1.7 | 4065 | 0.3 | 1.7 | 5.7 | 5.4 | |
N/A | Median | 4612 | −0.1 | 0.1 | 1.4 | 1.7 | 4093 | 0.4 | 1.7 | 6.0 | 5.4 | |
Weeks 13, 17, 22 | ||||||||||||
Pentavalent | Zimbabwe | 1246 | 0.3 | 1.7 | 4.9 | 4.6 | 1082 | 1.1 | 5.3 | 14.0 | 12.9 |
IQR: interquartile range; N/A: not applicable.
a Schedule is the target week after birth to administer the first, second and third doses of vaccine.
b Vaccination schedule in these countries includes a birth dose of hepatitis B vaccine (monovalent), i.e. four doses in total.
Notes: Data were extracted from the most recent demographic and health survey (survey year range: 2005–2014) in each country. Denominators are weighted. Delayed vaccination was vaccine dose received more than 4 weeks after the target week in the national vaccination schedule. Negative values indicate vaccination before the recommended target week; 0.0 indicates no delays.